Annual report pursuant to Section 13 and 15(d)

Note 8 - STOCKHOLDERS' DEFICIT (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights

v3.19.1
Note 8 - STOCKHOLDERS' DEFICIT (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]    
Balance Outstanding, Number of Shares   234,375
Balance Outstanding, Weighted Average Exercise Price $ 0.40 $ 0.40
Balance Outstanding, Weighted Average Remaining Contractual Term 4 years 262 days 5 years
Balance Outstanding, Aggregate Intrinsic Value $ 0 $ 0
Balance Exercisable, Number of Shares 402,250  
Balance Exercisable, Weighted Average Exercise Price $ 0.40  
Balance Exercisable, Weighted Average Remaining Contractual Term 4 years 262 days  
Balance Exercisable, Aggregate Intrinsic Value $ 0  
Granted, Number of Shares 167,875  
Granted, Weighted Average Exercise Price $ 0.40  
Granted, Weighted Average Remaining Contractual Term 5 years  
Forfeited, Number of Shares 0  
Forfeited, Weighted Average Exercise Price $ 0  
Exercised, Number of Shares 0  
Exercised, Weighted Average Exercise Price $ 0  
Expired, Number of Shares 0  
Expired, Weighted Average Exercise Price $ 0  
Balance Outstanding, Number of Shares 402,250